Institutional
27 de July de 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
29 de July de 2025
Flávia Tremura was recognized as Lexology Legal Influencer
We are pleased to announce that our partner Flávia Tremura has been recognized as a Lexology Legal Influencer in Intellectual Property for … Flávia Tremura was recognized as Lexology Legal Influencer
3 de July de 2025
Kasznar Leonardos is shortlisted as Firm of the Year at the LMG Life Sciences Americas Awards
We are proud to announce that Kasznar Leonardos has been shortlisted as a finalist in the “Firm of the Year” category at … Kasznar Leonardos is shortlisted as Firm of the Year at the LMG Life Sciences Americas Awards
26 de June de 2025
Kasznar Leonardos was ranked in Chambers & Partners Brazil: Industries & Sectors 2025
We are proud to announce that Kasznar Leonardos has been ranked in the Chambers Brazil Guide: Industries & Sectors 2025. We were … Kasznar Leonardos was ranked in Chambers & Partners Brazil: Industries & Sectors 2025